Page last updated: 2024-08-23

prednimustine and Hodgkin Disease

prednimustine has been researched along with Hodgkin Disease in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (42.86)	18.7374
1990's	9 (42.86)	18.2507
2000's	2 (9.52)	29.6817
2010's	1 (4.76)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M	1
Bischof, H; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Fischer, R; Georgii, A; Glunz, A; Greil, R; Hansmann, ML; Hasenclever, D; Hermann, R; Koch, B; Koch, P; Loeffler, M; Mueller, RP; Munker, R; Oertel, J; Paulus, U; Pfistner, B; Roller, S; Rueffer, U; Schalk, KP; Schober, T; Sieber, M; Stein, H; Tesch, H; von Kalle, K; Willich, N; Worst, P	1
Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M	1
Calvert, AH; Harrap, KR; McElwain, TJ; Newell, DR	1
Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N	1
Ammendolia, I; Babini, L; Barbieri, E; Bendandi, M; Fiacchini, M; Gherlinzoni, F; Neri, S; Perini, F; Salvucci, M; Zinzani, PL	1
Bányai, A; Illés, A; Szegedi, G	1
Gander, M; Leyvraz, S; Monnerat, C	1
Harrap, KR; Hart, LI; Newell, DR	1
Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S	1
Bourstyn, E; Brice, P; Colin, P; D'Agay, MF; Extra, JM; Fermand, JP; Fermé, C; Frija, J; Lepage, E; Miclea, JM	1
Andreopoulos, D; Glöckner, WM; Klose, KC	1
Eckhardt, S; Fleischmann, T; Szántó, I	2
Saal, JG; Steinke, B; von Hirschhausen, R	1
Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S	2
Bonadonna, G; Santoro, A; Valagussa, P	1
Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G	1
Bladé, J; Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C	1
Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C	1

Reviews

1 review(s) available for prednimustine and Hodgkin Disease

Article	Year
[Treatment of advanced stage Hodgkin disease with CCNU, etoposide and prednimustine (CEP)]. Orvosi hetilap, 1994, May-29, Volume: 135, Issue:22 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine	1994

Trials

5 trial(s) available for prednimustine and Hodgkin Disease

Article	Year
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine	2004
CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease. Tumori, 1994, Dec-31, Volume: 80, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Recurrence; Survival Analysis; Treatment Outcome	1994
Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP). Oncology, 1991, Volume: 48, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednimustine	1991
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Annals of internal medicine, 1986, Volume: 104, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine	1986
Prednimustine treatment in malignant lymphomas. Oncology, 1989, Volume: 46, Issue:4 Topics: Adult; Aged; Chlorambucil; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednimustine; Remission Induction	1989

Other Studies

15 other study(ies) available for prednimustine and Hodgkin Disease

Article	Year
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine	2011
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease. Annals of hematology, 2004, Volume: 83, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine	2004
Studies on the pharmacokinetics of chlorambucil and prednimustine in man. British journal of clinical pharmacology, 1983, Volume: 15, Issue:2 Topics: Administration, Oral; Chlorambucil; Hodgkin Disease; Humans; Injections, Intravenous; Kinetics; Prednimustine	1983
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood, 1995, Nov-15, Volume: 86, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine	1995
A rare case of prednimustine-induced myoclonus. Journal of the National Cancer Institute, 1997, Jan-15, Volume: 89, Issue:2 Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mitochondria; Myoclonus; Phosphorylation; Prednimustine	1997
Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography. Journal of chromatography, 1979, Sep-11, Volume: 164, Issue:1 Topics: Chlorambucil; Chromatography, High Pressure Liquid; Hodgkin Disease; Humans; Prednimustine	1979
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine	1990
Surgical restaging of advanced Hodgkin's disease after first line chemotherapy. European journal of haematology, 1991, Volume: 46, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Liver; Lymph Nodes; Neoplasm Staging; Prednimustine; Procarbazine; Spleen; Vinblastine	1991
[Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1991, Volume: 155, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Prednimustine; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine	1991
Treatment of advanced Hodgkin's disease with lomustine, etoposide, and prednimustine. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Lomustine; Prednimustine	1990
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. Seminars in oncology, 1986, Volume: 13, Issue:1 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine	1986
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Italy; Lomustine; Male; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine	1988
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients]. Sangre, 1988, Volume: 33, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine	1988
Third-line salvage chemotherapy in Hodgkin's disease. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine	1985
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustine. Cancer treatment reports, 1986, Volume: 70, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Neoplasm Staging; Prednimustine	1986